Valero Energy Corporation vs GeneDx Holdings Corp — how do they compare? Valero Energy Corporation trades at $441.76 (market cap $127.78B), while GeneDx Holdings Corp trades at $67.75 (market cap $2.02B). The key difference: Valero Energy Corporation is far larger — about 63.3× GeneDx Holdings Corp's market cap, and Valero Energy Corporation pays a 1.08% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Valero Energy Corporation for 56 Days and GeneDx Holdings Corp for 19 Days on average.
| VLO | WGS | |
|---|---|---|
Market Cap | $127.78B | $2.02B |
Volume | 2,570,225 | 734,640 |
Sector | Energy | Health |
52-Week High | $443.80 | $167.51 |
52-Week Low | $156.39 | $34.51 |
Typical Hold Time | 56 Days | 19 Days |
Enterprise Value | $131.26B | $2.05B |
Dividend Yield | 1.08% | — |
Signals from Pluang's Aura AI — not financial advice
Valero Energy (VLO) trades at $424.10, up 1.16% today, near its 52-week high. The stock exhibits bullish technical signals with strong moving average alignment and has beaten earnings estimates for three consecutive quarters. Revenue declined to $122.69 billion in 2025, but net income margin improved to 5.17%. Analyst consensus is bullish with a $408.10 price target, and recent news highlights institutional buying and refining margin strength.
Outlook remains positive driven by earnings beats and supportive refining margins, but risks include potential diesel export policy changes and volatile energy markets. The stock's high RSI suggests near-term overbought conditions, yet fundamental improvements and strong cash flow projections for 2026 provide a solid foundation for continued investor interest.
GeneDx (WGS) trades at $68.50, down 0.04% with a bearish technical signal despite bullish oscillators showing oversold conditions. The company reported mixed Q2 2026 results with revenue of $114.4M beating expectations but net income margin remains negative at -23.4%. Recent developments include new product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus targets $81.00 (18% upside), fundamental challenges persist with negative profitability metrics and high valuation multiples. The stock faces execution risks amid competitive genomics landscape, but operational improvements and testing volume growth provide potential catalysts for recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →